Litcius/Paper detail

Seizures secondary to zolpidem withdrawal

Aniel D. Russo, Michael Hodgman, Vincent Calleo

2020Clinical Toxicology6 citationsDOI

Abstract

To the EditorZolpidem is FDA approved for the treatment of insomnia. It is a hypnotic agent that is structurally unrelated to benzodiazepines, barbiturates, and many other drugs with hypnotic prope...

Topics & Concepts

ZolpidemHypnoticMedicineZopicloneInsomniaAnesthesiaPharmacologyPsychiatryPsychologyEpilepsy research and treatmentDiet and metabolism studies
Seizures secondary to zolpidem withdrawal | Litcius